{
    "organizations": [],
    "uuid": "78eeaa0964103af390b126dd8851bbd9aa315186",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kangmei-pharmaceutical-plans-debt/brief-kangmei-pharmaceutical-plans-debt-financing-instruments-and-bonds-to-invest-in-zhuhai-headquarters-idUSH9N1S101T",
    "ord_in_thread": 0,
    "title": "BRIEF-Kangmei Pharmaceutical Plans Debt Financing Instruments And Bonds, To Invest In Zhuhai Headquarters",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) - Kangmei Pharmaceutical Co Ltd :\n* SAYS IT PLANS TO ISSUE UP TO 10.0 BILLION YUAN ($1.58 billion) DEBT FINANCING INSTRUMENTS\n* SAYS IT PLANS TO ISSUE UP TO 6.0 BILLION YUAN BONDS * SAYS IT PLANS TO INVEST 1.1 BILLION YUAN TO BUILD HEADQUARTER BUILDING IN ZHUHAI CITY Source text in Chinese: bit.ly/2HpnyNk ; bit.ly/2KbS8aY ; bit.ly/2JrA3on Further company coverage: ($1 = 6.3194 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-04-25T19:59:00.000+03:00",
    "crawled": "2018-04-26T20:37:25.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "kangmei",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "plan",
        "issue",
        "billion",
        "yuan",
        "billion",
        "debt",
        "financing",
        "instrument",
        "say",
        "plan",
        "issue",
        "billion",
        "yuan",
        "bond",
        "say",
        "plan",
        "invest",
        "billion",
        "yuan",
        "build",
        "headquarter",
        "building",
        "zhuhai",
        "city",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}